Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsShirit Einav, Jeffrey S. Glenn, Robert McDowell, Wenjin Yang, Hadas Dvory-Sobol
Life of this patent
Estimating the term…
Abstract
Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like.
Claims6
A pharmaceutical composition for treating a host having a viral infection for a virus from the Flaviviridae family of viruses, comprising an inhibiting agent, wherein the inhibiting agent has the following structure:
A pharmaceutical composition for treating a host having a viral infection for a virus from the Flaviviridae family of viruses, comprising an inhibiting agent, wherein the inhibiting agent has the following structure:
- wherein R1 is
- wherein R2 is
- n is 1, and where X is
- wherein each of R4-R7 is independently selected from the group consisting of:
Dependencies are inferred from the claim text.